FY17 saw steady underlying growth in the investment portfolio and recurring earnings. Overall returns were further enhanced by positive revaluation movements reflecting continued tightening in market yields. Investment in development schemes had a limited impact on earnings in FY17 but completions and continuing acquisitions from a strong pipeline offer good growth prospects. The dividend has been increased and MedicX Fund (MXF) expects to pay 6.04p in respect of FY18, a yield of 7.1%, suppor
19 Dec 2017
MedicX Fund - Strong investment pipeline to continue progress
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
MedicX Fund - Strong investment pipeline to continue progress
Medicx Fund (MXF:LON) | 0 0 0.0% | Mkt Cap: 426.9m
- Published:
19 Dec 2017 -
Author:
Martyn King -
Pages:
13
FY17 saw steady underlying growth in the investment portfolio and recurring earnings. Overall returns were further enhanced by positive revaluation movements reflecting continued tightening in market yields. Investment in development schemes had a limited impact on earnings in FY17 but completions and continuing acquisitions from a strong pipeline offer good growth prospects. The dividend has been increased and MedicX Fund (MXF) expects to pay 6.04p in respect of FY18, a yield of 7.1%, suppor